LFCR Lifecore Biomedical, Inc.
Stock · NasdaqGS · United States · Healthcare · US5147661046
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Lifecore Biomedical, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
6.36 USD
-0.63%
52-week range
3.63 – 8.98
Dividend yield—
Market cap241.1M
NowoTrade score
2 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:53. Information, not advice.
Results
Next results
24 Feb 2027
in 108 days · 08:00 · estimate -0.10
Last results
-1.08 vs -0.30 estimated
04 Nov 2026 · Miss -263.0%
Beat the estimate
3 of 12
8 missed · 1 in line
Average surprise
-110.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 08:00 | -0.10 | — | — | Upcoming |
| 04 Nov 2026 07:00 | -0.30 | -1.08 | -263.0% | Miss |
| 05 Aug 2026 07:00 | -0.22 | -0.19 | +14.6% | Beat |
| 06 May 2026 07:00 | -0.29 | -0.43 | -48.3% | Miss |
| 16 Mar 2026 08:00 | -0.16 | -0.16 | 0.0% | In line |
| 03 Apr 2025 16:00 | -0.15 | -0.47 | -213.3% | Miss |
| 02 Jan 2025 16:00 | -0.30 | -0.20 | +34.1% | Beat |
| 04 Oct 2024 07:00 | -0.46 | -0.37 | +19.5% | Beat |
| 26 Aug 2024 17:00 | 0.16 | -0.20 | -225.0% | Miss |
| 09 Aug 2024 17:00 | -0.13 | -0.31 | -140.6% | Miss |
| 31 Aug 2023 07:00 | -0.07 | -0.11 | -50.7% | Miss |
| 01 Jun 2023 07:00 | -0.18 | -0.51 | -183.3% | Miss |
| 16 Mar 2023 16:00 | -0.11 | -0.42 | -265.2% | Miss |
| 06 Oct 2022 07:00 | -0.17 | -0.32 | -90.1% | Miss |
| 10 Aug 2022 16:00 | -0.01 | -0.01 | +25.0% | Beat |
| 05 Apr 2022 16:00 | -0.03 | -0.08 | -166.7% | Miss |
| 05 Jan 2022 16:00 | -0.09 | -0.22 | -149.5% | Miss |
| 29 Sep 2021 16:00 | -0.12 | -0.23 | -98.3% | Miss |
| 28 Jul 2021 16:00 | -0.02 | -0.10 | -525.0% | Miss |
| 07 Apr 2021 16:00 | — | -0.19 | -9,400.0% | Miss |
| 06 Jan 2021 16:00 | 0.03 | 0.02 | -20.0% | Miss |
| 06 Oct 2020 16:00 | -0.13 | -0.38 | -188.6% | Miss |
| 11 Aug 2020 16:00 | -0.56 | -0.52 | +6.6% | Beat |
| 31 Mar 2020 17:00 | -0.01 | -0.39 | -3,800.0% | Miss |
| 02 Jan 2020 16:00 | -0.06 | -0.16 | -166.7% | Miss |
| 01 Oct 2019 16:00 | -0.16 | -0.16 | -2.6% | Miss |
| 30 Jul 2019 16:00 | 0.03 | -0.01 | -137.5% | Miss |
| 03 Apr 2019 16:00 | 0.05 | 0.04 | -25.0% | Miss |
| 03 Jan 2019 16:00 | -0.02 | -0.02 | 0.0% | In line |
| 02 Oct 2018 16:00 | — | 0.01 | +200.3% | Beat |
| 31 Jul 2018 16:00 | 0.22 | 0.22 | +2.3% | Beat |
| 03 Apr 2018 16:00 | 0.09 | 0.09 | 0.0% | In line |
| 03 Jan 2018 16:00 | 0.01 | 0.02 | +60.0% | Beat |
| 26 Sep 2017 16:00 | 0.06 | 0.08 | +33.3% | Beat |
| 25 Jul 2017 16:00 | 0.09 | 0.09 | -2.7% | Miss |
| 04 Apr 2017 16:00 | 0.18 | 0.18 | +2.9% | Beat |
| 04 Jan 2017 16:00 | 0.06 | 0.05 | -18.6% | Miss |
| 27 Sep 2016 16:00 | 0.10 | 0.12 | +20.0% | Beat |
| 26 Jul 2016 16:00 | 0.15 | 0.17 | +10.9% | Beat |
| 29 Mar 2016 16:00 | 0.03 | -0.78 | -2,700.0% | Miss |
| 05 Jan 2016 16:00 | 0.06 | 0.07 | +10.5% | Beat |
| 29 Sep 2015 16:00 | 0.13 | 0.11 | -14.1% | Miss |
| 28 Jul 2015 16:00 | 0.19 | 0.15 | -21.9% | Miss |
| 31 Mar 2015 16:00 | 0.14 | 0.14 | -1.4% | Miss |
| 06 Jan 2015 16:00 | 0.12 | 0.12 | -1.4% | Miss |
| 07 Oct 2014 16:00 | 0.09 | 0.09 | -3.6% | Miss |
| 29 Jul 2014 16:00 | 0.18 | 0.17 | -4.8% | Miss |
| 25 Mar 2014 16:00 | 0.22 | 0.24 | +9.9% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 128.9M | +0.5% | -38.7M | -30.0% | -1.27 | -496.9% | -13.6M |
| 2024 | 128.3M | +24.2% | 12M | 9.4% | 0.32 | +109.4% | -18.1M |
| 2023 | 103.3M | -7.2% | -99.6M | -96.4% | -3.41 | -3.3% | -38.9M |
| 2022 | 111.3M | — | -116.7M | -104.9% | -3.30 | — | -52.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 10 Nov 2022 | 9.01 | 9.08 | 8.84 | 9.03 | +4.39% | 57,000 | |
| 09 Nov 2022 | 8.91 | 8.95 | 8.57 | 8.65 | -3.35% | 22,800 | |
| 08 Nov 2022 | 9.05 | 9.06 | 8.93 | 8.95 | -0.89% | 32,100 | |
| 07 Nov 2022 | 9.03 | 9.18 | 8.95 | 9.03 | -0.22% | 29,400 | |
| 04 Nov 2022 | 9.26 | 9.26 | 8.99 | 9.05 | -0.88% | 36,500 | |
| 03 Nov 2022 | 9.00 | 9.25 | 8.97 | 9.13 | -0.33% | 44,000 | |
| 02 Nov 2022 | 9.56 | 9.66 | 9.12 | 9.16 | -5.37% | 48,000 | |
| 01 Nov 2022 | 9.85 | 9.99 | 9.65 | 9.68 | -2.71% | 48,700 | |
| 31 Oct 2022 | 9.86 | 10.50 | 9.84 | 9.95 | +0.40% | 150,500 | |
| 28 Oct 2022 | 9.27 | 10.00 | 9.21 | 9.91 | +7.72% | 71,300 | |
| 27 Oct 2022 | 8.74 | 9.35 | 8.74 | 9.20 | +7.48% | 73,200 | |
| 26 Oct 2022 | 8.53 | 8.76 | 8.50 | 8.56 | +0.94% | 48,300 | |
| 25 Oct 2022 | 8.13 | 8.66 | 8.13 | 8.48 | +4.43% | 56,300 | |
| 24 Oct 2022 | 8.08 | 8.16 | 8.06 | 8.12 | +0.37% | 334,700 | |
| 21 Oct 2022 | 8.16 | 8.28 | 8.07 | 8.09 | 0.00% | 43,300 | |
| 20 Oct 2022 | 8.14 | 8.15 | 8.00 | 8.09 | +0.37% | 36,900 | |
| 19 Oct 2022 | 8.30 | 8.30 | 8.00 | 8.06 | -2.66% | 53,100 | |
| 18 Oct 2022 | 8.40 | 8.61 | 8.23 | 8.28 | 0.00% | 48,900 | |
| 17 Oct 2022 | 8.28 | 8.69 | 8.23 | 8.28 | +1.22% | 51,300 | |
| 14 Oct 2022 | 8.21 | 8.30 | 8.11 | 8.18 | -0.73% | 50,400 | |
| 13 Oct 2022 | 7.98 | 8.35 | 7.98 | 8.24 | +2.23% | 61,900 | |
| 12 Oct 2022 | 8.18 | 8.24 | 8.03 | 8.06 | -2.07% | 54,100 | |
| 11 Oct 2022 | 8.01 | 8.32 | 7.88 | 8.23 | +2.24% | 116,900 | |
| 10 Oct 2022 | 8.32 | 8.32 | 8.02 | 8.05 | -2.31% | 65,400 | |
| 07 Oct 2022 | 8.57 | 8.60 | 8.21 | 8.24 | -5.40% | 78,700 |
Page 41 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Lifecore Biomedical: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 12:27
- Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update (opens in a new tab) 04 Nov 2026 12:05
- Lifecore Biomedical Q3 EPS $(1.08) Misses $(0.28) Estimate, Sales $25.322M Miss $26.699M Estimate (opens in a new tab) Benzinga · 04 Nov 2026 08:24
- Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing? (opens in a new tab) Insider Monkey · 23 Oct 2026 18:34
- Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity (opens in a new tab) Insider Monkey · 17 Aug 2026 16:29
- Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 12 Aug 2026 16:31
- Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Aug 2026 13:30
- Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ... (opens in a new tab) GuruFocus.com · 05 Aug 2026 20:04
- Lifecore Biomedical Q2 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Aug 2026 14:04
- Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market (opens in a new tab) Insider Monkey · 15 Jul 2026 14:11
- Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? (opens in a new tab) Insider Monkey · 30 Jun 2026 14:11
- Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook (opens in a new tab) Simply Wall St. · 13 Jun 2026 06:06
- How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations (opens in a new tab) Simply Wall St. · 29 May 2026 02:03
- Lifecore Biomedical Q1 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 May 2026 14:07
- Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR) (opens in a new tab) Insider Monkey · 27 Apr 2026 12:47
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 6.40 USD
- Market cap
- 241.1M
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 8.4 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 | — |
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 0.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.3 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 2.9 / 10 |
|
- Score capped at 50: three or more warnings
- Heavy debt: net debt is 33.4× EBITDA
- Thin interest cover: operating profit is only -0.5× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -8.15× | Weak | 14.89× |
| Price / book | -3.29× | Weak | 3.8× |
| Price / sales | 2.26× | Fair | 3.19× |
| EV / EBITDA | 103.49× | Weak | 12.61× |
| Free cash flow yield | -5.6% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 27.5% | Fair | 58.6% |
| Operating margin | -3.5% | Weak | 7.6% |
| Net margin | -66.8% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 5% | Fair | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 97.92× | Weak | 0.48× |
| Net debt / EBITDA | 33.38× | Weak | 1.6× |
| Interest cover | -0.54× | Weak | 2.65× |
| Current ratio | 3.84× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow LFCR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.